EA200601889A1 - Лечение инфекционных заболеваний - Google Patents

Лечение инфекционных заболеваний

Info

Publication number
EA200601889A1
EA200601889A1 EA200601889A EA200601889A EA200601889A1 EA 200601889 A1 EA200601889 A1 EA 200601889A1 EA 200601889 A EA200601889 A EA 200601889A EA 200601889 A EA200601889 A EA 200601889A EA 200601889 A1 EA200601889 A1 EA 200601889A1
Authority
EA
Eurasian Patent Office
Prior art keywords
treatment
infectious diseases
chemical attack
compounds
derivatives
Prior art date
Application number
EA200601889A
Other languages
English (en)
Other versions
EA016803B1 (ru
Inventor
кДжэлдгаард Гиверкман Биргит
Original Assignee
Бкг Фарма Апс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Бкг Фарма Апс filed Critical Бкг Фарма Апс
Publication of EA200601889A1 publication Critical patent/EA200601889A1/ru
Publication of EA016803B1 publication Critical patent/EA016803B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

Данное изобретение направлено на применение соединений, чувствительных к химическому воздействию, в частности производных тиоксантена и производных фенотиазина, для лечения инфекционных заболеваний в комбинации с противоинфекционным агентом. Изобретение, более того, относится к композициям, включающим указанные соединения, чувствительные к химическому воздействию и противоинфекционным агентам.
EA200601889A 2004-04-30 2005-04-29 Лечение инфекционных заболеваний EA016803B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200400680 2004-04-30
DKPA200401716 2004-11-08
PCT/DK2005/000294 WO2005105145A1 (en) 2004-04-30 2005-04-29 Treatment of infectious diseases

Publications (2)

Publication Number Publication Date
EA200601889A1 true EA200601889A1 (ru) 2007-06-29
EA016803B1 EA016803B1 (ru) 2012-07-30

Family

ID=34965444

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200601889A EA016803B1 (ru) 2004-04-30 2005-04-29 Лечение инфекционных заболеваний

Country Status (13)

Country Link
US (1) US20080318970A1 (ru)
EP (2) EP1744781B1 (ru)
JP (2) JP5026255B2 (ru)
CN (1) CN1976723B (ru)
AU (1) AU2005237208B2 (ru)
CA (1) CA2564684C (ru)
DK (1) DK1744781T3 (ru)
EA (1) EA016803B1 (ru)
ES (1) ES2390226T3 (ru)
HK (1) HK1104460A1 (ru)
MX (1) MXPA06012566A (ru)
NO (1) NO20065469L (ru)
WO (1) WO2005105145A1 (ru)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2009007235A (es) * 2007-01-05 2009-10-16 Bkg Pharma Aps "derivados de tioxanteno utiles para el tratamiento de enfermedades infecciosas.".
EP2246349A1 (en) 2009-04-20 2010-11-03 BKG Pharma ApS Treatment of infectious diseases
CN103781481B (zh) * 2011-08-02 2018-12-14 亥姆霍兹慕尼黑中心-德国环境健康研究中心 (Gmbh) 吩噻嗪衍生物对malt1蛋白酶的选择性抑制
EP2758403B1 (en) 2011-09-21 2016-04-27 Inception Orion, Inc. Tricyclic compounds useful as neurogenic and neuroprotective agents
US20140309275A1 (en) * 2011-09-29 2014-10-16 Emory University Sphingosine Analogs, Compositions, and Methods Related Thereto
CN104812394B (zh) * 2012-11-26 2018-10-19 开普敦大学 吩噻嗪衍生物及其治疗肺结核的用途
KR101798176B1 (ko) * 2014-12-16 2017-11-15 주식회사 엠디헬스케어 세균 유래의 나노소포체를 이용한 세균성 감염질환 원인균 동정방법
JP6168673B2 (ja) * 2015-10-07 2017-07-26 協和発酵キリン株式会社 アリールアルキルアミン化合物含有医薬組成物
CN109641889A (zh) 2016-06-23 2019-04-16 百欧伊米克思有限公司 抗感染杂环化合物及其用途
WO2018070874A1 (en) * 2016-10-12 2018-04-19 Rijksuniversiteit Groningen Means and methods for reducing or avoiding antibiotic resistance and spread of virulence in human pathogens
EP3958975A1 (en) * 2019-04-24 2022-03-02 Københavns Universitet New class of antibiotics having low mic-values towards different strains of bacteria
CN112353805A (zh) * 2020-11-17 2021-02-12 北京化工大学 氟哌噻吨在治疗和预防柯萨奇病毒感染中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE578983A (ru) 1958-05-29
DE1518325B1 (de) 1960-03-07 1970-08-27 Smith Kline French Lab Basisch substituierte Trifluormethylxanthene und deren nicht toxische Saeureadditionssalze und Verfahren zu deren Herstellung
HU190078B (en) * 1983-03-25 1986-08-28 Egyt Gyogyszervegyeszeti Gyar,Hu Process for producing new antibacterial pharmaceutical composition and/or food-premix
NZ228748A (en) * 1988-04-20 1991-07-26 Merrell Dow Pharma Treating drug-resistant protozoal infections with a tricyclic compound and an antiprotozoal agent: composition and kit therefor
US6569853B1 (en) 2000-11-06 2003-05-27 Combinatorx, Incorporated Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disorders
US6989396B2 (en) * 2001-04-12 2006-01-24 The Board Of Trustees Of The University Of Illinois Tropane alkaloid multidrug resistance inhibitors from Erythroxylum pervillei and use of the same
WO2002089810A1 (en) * 2001-05-07 2002-11-14 United States Army Medical Research And Materiel Command Chemosensitizing agents against chloroquine resistant plasmodium falciparum and methods of making and using thereof
JP4570357B2 (ja) 2001-07-06 2010-10-27 ライフサイクル ファーマ エー／エス 制御された凝集
WO2003062388A2 (en) * 2002-01-16 2003-07-31 The Regents Of The University Of California Inhibition of rna function
AU2003205543A1 (en) 2003-01-14 2004-08-10 Lifecycle Pharma A/S Dry dispersions
DK1689405T3 (da) * 2003-11-13 2012-02-20 Noa Sic Aps Thioridazin og derivater deraf til reversering af anti-mikrobiel resistens

Also Published As

Publication number Publication date
JP2012082219A (ja) 2012-04-26
EP1744781B1 (en) 2012-07-04
CA2564684A1 (en) 2005-11-10
US20080318970A1 (en) 2008-12-25
EA016803B1 (ru) 2012-07-30
EP2260870A3 (en) 2012-12-26
MXPA06012566A (es) 2007-05-09
CN1976723B (zh) 2010-12-29
HK1104460A1 (en) 2008-01-18
WO2005105145A1 (en) 2005-11-10
AU2005237208A1 (en) 2005-11-10
JP5026255B2 (ja) 2012-09-12
EP2260870A2 (en) 2010-12-15
CN1976723A (zh) 2007-06-06
AU2005237208B2 (en) 2009-12-03
DK1744781T3 (da) 2012-10-15
CA2564684C (en) 2010-10-26
JP2007535510A (ja) 2007-12-06
EP1744781A1 (en) 2007-01-24
NO20065469L (no) 2007-01-24
ES2390226T3 (es) 2012-11-07

Similar Documents

Publication Publication Date Title
EA200601889A1 (ru) Лечение инфекционных заболеваний
ATE469155T1 (de) Cyclopropyl-fusionierte indolbenzazepin-hcv-ns5b- hemmer
DK1987038T3 (da) HCV NS5B-hæmmere
EA200800371A1 (ru) Ингибиторы ns3 протеазы вгс
EA200802346A1 (ru) Циклопропилконденсированные индолобензазепиновые ингибиторы белка ns5b вируса гепатита с
CY1111050T1 (el) Φωσφονικα, μονοφωσφοναμιδικα, διφωσφοναμιδικα για την αγωγη των ιϊκων παθησεων
EA200800178A1 (ru) Ингибиторы вируса гепатита с (hcv)
EA200900298A1 (ru) Ингибиторы вируса гепатита с
EA200802213A1 (ru) Способы лечения заболеваний крови
MA33806B1 (fr) Inhibiteurs du virus de l'hepatite c
DK2209789T3 (da) Cyclopropyl-kondenserede indolobenzazepin HCV NS5B-hæmmere
EA200700851A1 (ru) Получение и применение бифенил-4-илкарбониламинокислотных производных для лечения ожирения
EA200901241A1 (ru) Соединения для лечения гепатита с
EA200801997A1 (ru) Новые соединения
DK1973539T3 (da) Anvendelse af benzokondenserede heterocykliske sulfamidderivater til behandling af depression
ATE522532T1 (de) Verbindungen zur behandlung von hepatitis c
ATE551343T1 (de) Tetracyclische verbindungen zur behandlung von hepatitis c
EA201000277A1 (ru) Соединения для лечения гепатита с
DE602008004317D1 (de) Verbindungen zur behandlung von hepatitis c
EA200870089A1 (ru) Применение производных бензоконденсированного гетероциклического сульфамида для лечения злоупотребления психоактивным веществом и аддикции
ATE505473T1 (de) Cyclopropylkondensierte indolobenzazepinderivate zur behandlung von hepatitis c
DE602006005640D1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate als arzneimittel zur behandlung von unfruchtbarkeit
EA201170605A1 (ru) Циклоундекадепсипептидные соединения и применение указанных соединений в качестве лекарственного средства
CY1111778T1 (el) Παραγωγα θειοξανθενιου ως μοναδικοι αντιμολυσματικοι παραγοντες για χρηση στην αντιμετωπιση των μολυσματικων ασθενειων
EA200701813A1 (ru) Новые амидозамещенные 6-фенилфенантридины

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): BY RU